This ACTG study will evaluate the long-term safety, efficacy, and tolerance of Zidovudine to treat subjects with symptomatic HIV infections as manifested by early AIDS-related complex using the following criteria. (1) Prevention or delay of AIDS-defining opportunistic infections or malignancies. (2) Prevention or delay of advanced ARC. (3) Prolongation of survival. (4) Restoration of immune response. (5) Antiviral effect.
Showing the most recent 10 out of 426 publications